Age group | Without loxoscelisma (n = 30) | With loxoscelisma |
---|
Cutaneousb (n = 6) | Systemicb (n = 4) |
---|
Male | Female | Male | Female | Male | Female |
---|
18–29 | 11/36.7% | 16/53.3% | 1/16.7% | 2/33.3% | 2/50% | 1/25% |
30–60 | 3/10% | – | 2/33.3% | 1/16.7% | – | 1/25% |
- aSamples of serum obtained under informed consent (procedure approved by the Research Ethics Committee of the Universidad de Antofagasta – CEIC-UA)
- bAccording to clinical history and/or direct observation of dermonecrotic lesion. Samples are represented as number and percentage (n/%)